These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 5894066)

  • 1. [Studies on the serum and organs concentration of alpha-ethyl-thioisonicotinamide (1314Th)].
    Hirata R
    Sapporo Igaku Zasshi; 1965; 27(3):117-26. PubMed ID: 5894066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evolution of serum concentrations of ethionamide (TH 1413) and ethionamide sulfoxide (TH 1405) after oral administration of these tuberculostatic agents in man].
    Bieder A; Brunel P; Roquet-Ghaye J; Kreis B
    Rev Fr Etud Clin Biol; 1966 Apr; 11(4):419-23. PubMed ID: 5944589
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the antituberculous activity of alpha-ethyl-thioisonicotinamide-methanesulfonate and its side effects.
    Naito M; Maekawa N; Tsukuma S; Kawai M; Kuze F
    Acta Tuberc Jpn; 1966 Mar; 15(2):71-83. PubMed ID: 5947728
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDIES ON THE SERUM CONCENTRATION OF 1314TH].
    HIRATA R
    Naika Hokan; 1964 Apr; 11():173-6. PubMed ID: 14169581
    [No Abstract]   [Full Text] [Related]  

  • 5. [Simultaneous determination of INH and ethionamide concentration in the lung].
    Eule H; Werner E
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):335-8. PubMed ID: 5897863
    [No Abstract]   [Full Text] [Related]  

  • 6. [APROPOS OF THE TREATMENT BY INTRAVENOUS ETHIONAMIDE (1314TH) OF SEVERE RECURRENCES OF PULMONARY TUBERCULOSIS].
    LAMY P; BRIQUEL P; ANTHOINE D; JACQUIN AB; BERTHEAU JM
    Ann Med Nancy; 1963 Nov; 2():1532-42. PubMed ID: 14111517
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protective action of sodium succinate in ethionamide poisoning].
    Maliuk VI; Korzhov VI
    Farmakol Toksikol; 1982; 45(1):90-2. PubMed ID: 7056389
    [No Abstract]   [Full Text] [Related]  

  • 8. [Concentration of histamine in the sputum of patients with chronic obstructive lung diseases and chronic pulmonary tuberculosis].
    Jakupi M; Mandura I; Kastrati B; Haxhiu MA
    Plucne Bolesti Tuberk; 1983; 35(1-4):103-7. PubMed ID: 6657791
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tissue gas exchange in tuberculous foci and in walls of caverns in animals sensitive to and resistant to tuberculosis].
    Zhigalina LI
    Probl Tuberk; 1966; 44(2):66-73. PubMed ID: 5984591
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism of macroergic phosphorus compounds in different courses of experimental tuberculosis].
    Tsitko TM
    Probl Tuberk; 1966; 44(3):67-9. PubMed ID: 5993672
    [No Abstract]   [Full Text] [Related]  

  • 11. [Different sensitivity biochemical mechanisms to mycobacterium tuberculosis of guinea pigs and rats].
    Pavlov VA
    Probl Tuberk; 1998; (2):30-2. PubMed ID: 9613182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of ethionamide or 1314 TH in the treatment of tuberculosis].
    Farias CE
    Rev Esp Tuberc; 1965 Sep; 34(366):359-68. PubMed ID: 5852459
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oxidative phosphorylation in experimental tuberculosis and after administration of proteolysis inhibitors].
    Ivaniuta OM; Maliuk VI; Panasiuk AV; Tumanova TA; Zamdborg IuL
    Probl Tuberk; 1983 Jun; (6):55-7. PubMed ID: 6878223
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ultrastructural and metabolic changes in the lungs in experimental tuberculosis].
    Erokhin VV
    Probl Tuberk; 1981 Apr; (4):61-4. PubMed ID: 7255376
    [No Abstract]   [Full Text] [Related]  

  • 15. [How large is the tocopherol accumulation capacity of organs? Long term trials with various high oral alpha-tocopherol doses administered to rats and guinea pigs].
    Elmadfa I; Walter A
    Int J Vitam Nutr Res; 1981; 51(3):284-92. PubMed ID: 7319728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative determinations of concentration of ethionamide in the blood and urine].
    Gajewska E
    Gruzlica; 1967 Jun; 35(6):573-6. PubMed ID: 6051999
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective intracellular accumulation of the major metabolite issued from the activation of the prodrug ethionamide in mycobacteria.
    Hanoulle X; Wieruszeski JM; Rousselot-Pailley P; Landrieu I; Locht C; Lippens G; Baulard AR
    J Antimicrob Chemother; 2006 Oct; 58(4):768-72. PubMed ID: 16895935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of treatment by ethionamide on the morphologic dynamics of experimental tuberculous inflammation].
    Diaconita G; Eskenasy A; Stoica E
    Poumon Coeur; 1965; 21(9):1115-24. PubMed ID: 5845716
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the antituberculous effectiveness of alpha-ethyl-thioisonicotinamide in tuberculosis in humans.
    BROUET G; MARCHE J; RIST N; CHEVALLIER J; LEMEUR G
    Am Rev Tuberc; 1959 Jan; 79(1):6-18. PubMed ID: 13606330
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a urinary colour test in the surveillance of ethionamide medication.
    Eidus L; Jessamine AG; Harnanansingh AM
    Can Med Assoc J; 1968 Sep; 99(9):413-5. PubMed ID: 5703280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.